Group One Trading’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
Other funds holding MRKR
NMC
BOCH
VCM
ACM
VFT
XT
Group One Trading's MRKR Position: Q1 2026 in Review
Group One Trading held its Marker Therapeutics (MRKR) position steady in Q1 2026 at 178 shares worth $231. The position accounts for ﹤0.01% of the portfolio, ranked #7387.
Group One Trading first reported a position in MRKR in Q2 2019 and has held it in 22 quarters since. The position peaked at $70K in Q3 2019. 35 funds tracked by Wall St. Rank hold MRKR as of Q1 2026.
- Group One Trading held 178 shares of Marker Therapeutics worth $231 as of Q1 2026.
- Group One Trading left its Marker Therapeutics share count unchanged in Q1 2026.
- Marker Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7387 holding.
- Group One Trading first reported a position in Marker Therapeutics in Q2 2019 and has held it in 22 quarters since.
- Group One Trading's Marker Therapeutics position peaked at $70K in Q3 2019.
- 35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.